Human insulin as safe and effective to treat type 2 diabetes as costlier insulin analogs

Patients with Type 2 diabetes who were treated with the newer generation of insulin analog drugs did not have substantially better outcomes than those treated with less costly human insulin, according to a study by Yale School of Medicine researchers and colleagues at Kaiser Permanente. The study is published in the June 23 issue of Journal of the American Medical Association.
Go to Source